Kate Burt
About Kate Burt
Kate Burt serves as the Vice President of Corporate Development at Wave Life Sciences, a position she has held since 2019. She has extensive experience in corporate development, having previously worked at GSK in various roles for over a decade.
Work at Wave Life Sciences
Kate Burt has served as the Vice President of Corporate Development at Wave Life Sciences since 2019. In this role, she is responsible for overseeing corporate development strategies and initiatives within the organization. Wave Life Sciences is located in Cambridge, Massachusetts, and focuses on developing transformative medicines for patients with genetic diseases. Her tenure at Wave Life Sciences has contributed to the company's growth and strategic direction in the biotechnology sector.
Experience at GSK
Before joining Wave Life Sciences, Kate Burt held several positions at GSK. She began her career there as the Director of Commercial Alliances and Transactions in Worldwide Business Development from 2002 to 2010. Following this role, she served as Senior Director of Corporate Development from 2010 to 2012. Since 2012, she has been the Head of Business Development for Emerging Markets, where she has focused on expanding GSK's presence in developing regions. Her extensive experience at GSK spans over a decade.
Education and Expertise
Kate Burt possesses a strong background in corporate development and business strategy within the pharmaceutical and biotechnology industries. Her expertise includes managing commercial alliances, business development initiatives, and corporate strategy. This knowledge has been instrumental in her roles at both Wave Life Sciences and GSK, where she has contributed to the advancement of business operations and strategic partnerships.
Professional Background
Kate Burt has built a comprehensive career in corporate development and business strategy. Her professional journey began at GSK, where she accumulated significant experience over multiple roles. This background laid the foundation for her current position at Wave Life Sciences. Her work has consistently involved strategic planning and execution, particularly in the context of business development and market expansion.